Yu-An Kung
Overview
Explore the profile of Yu-An Kung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
386
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee H, Chuang C, Huang C, Chuang T, Kung Y, Chiu C
Biomed J
. 2025 Feb;
:100834.
PMID: 39961391
Background: Limited research has explored the immunological effects of a second COVID-19 vaccine booster in older adults within Western Pacific countries. Methods: This study involved healthcare workers aged ≥65 years...
2.
Kung Y, Chuang C, Chen Y, Yang H, Li H, Chen C, et al.
J Formos Med Assoc
. 2024 Aug;
PMID: 39179492
The coronavirus disease 2019 (COVID-19) pandemic has sparked widespread concern globally, particularly with the Omicron variant and its sub-lineages emerging as the predominant cause of infection for nearly two years....
3.
Palanisamy S, Lee L, Kao C, Chen W, Wang H, Shen S, et al.
Sens Actuators B Chem
. 2023 May;
390:133960.
PMID: 37193120
The COVID-19 pandemic has become a global catastrophe, affecting the health and economy of the human community. It is required to mitigate the impact of pandemics by developing rapid molecular...
4.
Mackeown M, Kung Y, Davila-Calderon J, Ford W, Luo L, Henry B, et al.
J Biol Chem
. 2023 Feb;
299(4):103028.
PMID: 36805339
The emergence of SARS-CoV-2, which is responsible for the COVID-19 pandemic, has highlighted the need for rapid characterization of viral mechanisms associated with cellular pathogenesis. Viral UTRs represent conserved genomic...
5.
Chuang C, Huang C, Huang C, Chen Y, Kung Y, Chen C, et al.
J Clin Virol
. 2022 Nov;
157:105328.
PMID: 36399969
Objectives: We conducted a single-blinded, randomized trial to evaluate the safety, reactogenicity, and immunogenicity of heterologous booster vaccination in health care workers (HCW) who had received two doses of ChAdOx1...
6.
Kung Y, Huang S, Huang C, Liu K, Huang P, Yu K, et al.
Microbes Infect
. 2022 Sep;
25(1-2):105044.
PMID: 36096357
The World Health Organization has highlighted the importance of an international standard (IS) for severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) neutralizing antibody titer detection to calibrate diagnostic techniques. We applied...
7.
Kung Y, Lee K, Chiang H, Huang S, Wu C, Shih S
Microbiol Mol Biol Rev
. 2022 Mar;
86(2):e0002621.
PMID: 35343760
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The global COVID-19 pandemic continues to threaten the lives of hundreds of millions of people, with...
8.
Liu K, Gong Y, Huang C, Huang P, Yu K, Lee H, et al.
mSphere
. 2022 Feb;
7(1):e0088321.
PMID: 35107336
Considering the urgent demand for faster methods to quantify neutralizing antibody titers in patients with coronavirus (CoV) disease 2019 (COVID-19), developing an analytical model or method to replace the conventional...
9.
Kung Y, Chiang H, Li M, Gong Y, Chiu H, Hung C, et al.
mBio
. 2022 Jan;
13(1):e0271721.
PMID: 35038927
Enterovirus infections can cause severe complications, such as poliomyelitis, encephalitis, myocarditis, meningitis, neurological pulmonary edema, and even death. Here, we used genome-wide CRISPR screens to gain new insight into the...
10.
Chen Y, Kung Y, Janapatla R, Hsu M, Lien R, Chen J, et al.
Pediatr Neonatol
. 2021 Sep;
62(6):661-663.
PMID: 34580045
No abstract available.